ESR1 and depressive symptom measurement: As E2 can regulate gene expression after coupling with estrogen receptors (142), which are expressed within the midbrain raphe nucleus (the main reservoir of serotonergic neurons) (143, 144), this treatment may modulate the expression of genes that regulate serotonin neurotransmission implicated in depression.